glp-1 ra cardiovascular benefits and drawbacks of receptor agonist use. Abbreviations: Surprising Benefits of GLP-1 Medications

ACMSD catalyzes the decarboxylation of aminocarboxymuconate-semialdehyde (ACMS) into aminomuconic semialdehyde, which can then enter the citric acid cycle as acetyl-CoA, contributing to cellular respiration

Newer drugs target more than one metabolic receptor, which may produce greater effects on weight and blood sugar

Take the quiz here

We confirmed that lowering of Fas (activity) was beneficial to OLs since addition of Fas inhibitor C75 led to an increased differentiation in DA Wt but not in DA Gsta4 OLs

Kalra S, Das AK, Sahay RK, Baruah MP, Tiwaskar M, Das S et al (2019) Consensus recommendations on GLP-1 RA use in the management of type 2 diabetes mellitus: South Asian task force

10 WELL KNOWN IMPROVEMENTS: High intensity work capacity